Search results for "Myocardial infarction complications"

showing 10 items of 14 documents

Comparative Analysis of Patients with Acute Coronary and Cerebrovascular Syndromes from the National French Hospitalization Health Care System Databa…

2010

<i>Background:</i> Nationwide evaluations of the epidemiology of acute coronary syndrome (ACS) or cerebrovascular syndrome (CVS) are scarce. We aimed to analyze nationwide French data on patients referred to hospital for either ACS or CVS. <i>Methods:</i> Using the French national hospital discharge diagnosis records, all patients hospitalized between 2005 and 2008 with a diagnosis of ACS and CVS based on the ICD-10 were identified. We analyzed vascular risk factors and early outcomes in patients with a single hospitalization for ACS or CVS or for both ACV and CVS in a 2-month time window. <i>Results:</i> 1,187,643 patients were recorded. Among these, 638…

AdultMalemedicine.medical_specialtyAcute coronary syndromePediatricsAdolescentEpidemiologyHypercholesterolemiaMyocardial Infarctionfluids and secretionsRisk FactorsInternal medicineDiabetes mellitusAtrial FibrillationEpidemiologyDiabetes MellitusmedicineHumansHospital MortalityObesityRegistriesMyocardial infarctionAcute Coronary SyndromeStrokeAgedAged 80 and overInpatientsbusiness.industryAbsolute risk reductionAtrial fibrillationMiddle Agedequipment and suppliesmedicine.diseaseStrokeCerebrovascular DisordersHypertensionMyocardial infarction complicationsFemaleFranceNeurology (clinical)businessNeuroepidemiology
researchProduct

Copeptin Improves Early Diagnosis of Acute Myocardial Infarction

2010

ObjectivesEarly identification of myocardial infarction in chest pain patients is crucial to identify patients at risk and to maintain a fast treatment initiation.BackgroundThe aim of the current investigation is to test whether determination of copeptin, an indirect marker for arginin-vasopressin, adds diagnostic information to cardiac troponin in early evaluation of patients with suspected myocardial infarction.MethodsBetween January 2007 and July 2008, patients with suspected acute coronary syndrome were consecutively enrolled in this multicenter study. Copeptin, troponin T (TnT), myoglobin, and creatine kinase-myocardial band were determined at admission and after 3 and 6 h.ResultsOf 1,…

AdultMalemedicine.medical_specialtyAcute coronary syndromechest paindiagnosisMyocardial InfarctionChest painAngina PectorisCopeptinTroponin TPredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAgedTroponin TtroponinUnstable anginabusiness.industryMyoglobinTroponin IGlycopeptidescopeptinMiddle Agedmedicine.diseaseEarly DiagnosisCardiologyMyocardial infarction complicationsFemaleMyocardial infarction diagnosismedicine.symptombusinessCardiology and Cardiovascular MedicineBiomarkersJournal of the American College of Cardiology
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.

2005

The impact of metabolic syndrome after acute myocardial infarction (AMI) has not yet been studied. In a population-based sample of patients with AMI, we sought to determine the prevalence of metabolic syndrome in patients with AMI, its impact on hospital outcomes, and to assess the relative influence of each of the components of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III definition of metabolic syndrome on the risk of death and heart failure.A total of 633 unselected, consecutive patients hospitalized with AMI were categorized according to the NCEP ATP III metabolic syndrome criteria (presence of/=3 of the following: hyperglycemia; triglyceride level/=…

Blood GlucoseMalemedicine.medical_specialtyHeart diseasePopulationMyocardial InfarctionPredictive Value of TestsRisk FactorsInternal medicineInternal MedicinemedicineOdds RatioPrevalenceHumanscardiovascular diseasesMyocardial infarctionHospital MortalityIntensive care medicineeducationNational Cholesterol Education Programhealth care economics and organizationsAgedRetrospective StudiesMetabolic Syndromeeducation.field_of_studybusiness.industryRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseLipidsCreatinineMyocardial infarction complicationsFemaleFranceMetabolic syndromebusinessBiomarkersArchives of internal medicine
researchProduct

Association between chronic dental infection and acute myocardial infarction.

2008

Introduction: In patients with cardiovascular diseases several risk factors such as high blood pressure, diabetes, smoking and drinking habits, genetic disposition, and chronic inflammation must be considered. The aim of this study was to investigate whether there is a correlation between dental origin infections and the presence of an acutemyocardialinfarction(AMI).Methods:Atotalof125 patients who had experienced a myocardial infarction and 125healthyindividualswereincludedinthisstudy.Theoral examination was carried out following the consent of the ethics committee and the National Board for Radiation Protection and included the number of teeth, endodontically treated teeth, periodontal sc…

Blood GlucoseMalemedicine.medical_specialtyMyocardial InfarctionInfarctionDentistryDiabetes ComplicationsLeukocyte CountTooth LossSex FactorsRisk FactorsInternal medicineDiabetes mellitusPeriodontal Attachment LossmedicineTooth lossHumansPeriodontal PocketMyocardial infarctionObesityGeneral DentistryPeriodontal DiseasesAgedAged 80 and overTooth Nonvitalbiologybusiness.industryPeriapical DiseasesC-reactive proteinSmokingCase-control studyAge FactorsDental Pulp DiseasesMiddle Agedmedicine.diseaseRadiographyC-Reactive ProteinClinical attachment lossTooth DiseasesCase-Control StudiesChronic Diseasebiology.proteinMyocardial infarction complicationsFemalemedicine.symptomPeriodontal IndexbusinessGingival HemorrhageJournal of endodontics
researchProduct

Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acut…

2012

Background: Angiotensin-converting enzyme inhibitors (ACEIs) are largely employed for treating patients with left ventricular dysfunction (LVD), but their efficacy may be negatively affected by concomitant administration of acetylsalicylic acid (ASA), with some difference among the different compounds. Hypothesis: The interaction between ASA and the two ACEIs zofenopril and ramipril may result in a different impact on survival of cardiac patients, due to differences in the pharmacological properties of the two ACEIs. Methods: This phase IIIb, randomized, double-blind, parallel-group, multicenter, European study compared the safety and efficacy of zofenopril (60 mg/day) and ramipril (10 mg/d…

MaleCaptoprilTime FactorsMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsKaplan-Meier EstimateVentricular Function Leftlaw.inventionchemistry.chemical_compoundVentricular Dysfunction LeftRandomized controlled trialRamiprillawRisk FactorsOdds RatioMyocardial infarctionProspective Studieseducation.field_of_studyEjection fractionGeneral MedicineMiddle AgedZofenoprilEuropeHospitalizationTreatment OutcomeCardiologyDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinemedicine.drugRamiprilmedicine.medical_specialtySystolePopulationClinical InvestigationsRisk AssessmentDouble-Blind MethodInternal medicinemedicineHumanseducationAgedHeart FailureChi-Square DistributionAspirinbusiness.industryStroke Volumeacetylsalicylic acidmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryLogistic ModelschemistryAngiotensin-converting enzyme inhibitorHeart failureMyocardial infarction complicationsZofenopril ramipril myocardial infarctionbusinessPlatelet Aggregation Inhibitors
researchProduct

Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex

2016

Background Common ECG criteria such as ST-segment changes are of limited value in patients with suspected acute myocardial infarction (AMI) and bundle branch block or wide QRS complex. A large proportion of these patients do not suffer from an AMI, whereas those with ST-elevation myocardial infarction (STEMI) equivalent AMI benefit from an aggressive treatment. Aim of the present study was to evaluate the diagnostic information of cardiac troponin I (cTnI) in hemodynamically stable patients with wide QRS complex and suspected AMI. Methods In 417 out of 1818 patients presenting consecutively between 01/2007 and 12/2008 in a prospective multicenter observational study with suspected AMI a pro…

MaleCardiovascular ProceduresMyocardial Infarctionlcsh:MedicineCoronary Artery Disease030204 cardiovascular system & hematologyPathology and Laboratory MedicineBiochemistryVascular MedicineCoronary artery diseaseElectrocardiographyPatient Admission0302 clinical medicineTroponin IMedicine and Health SciencesMedicine030212 general & internal medicineMyocardial infarctionlcsh:ScienceStenosisMultidisciplinarymedicine.diagnostic_testbiologyMiddle AgedTroponinBioassays and Physiological Analysiscardiovascular systemCardiologyFemaleAlgorithmsResearch Articlemedicine.medical_specialtyCardiologySurgical and Invasive Medical ProceduresResearch and Analysis MethodsSensitivity and Specificity03 medical and health sciencesSigns and SymptomsDiagnostic MedicineInternal medicineHumansddc:610cardiovascular diseasesAgedCoronary RevascularizationBundle branch blockReceiver operating characteristicbusiness.industryRevascularizationElectrophysiological TechniquesAngioplastyTroponin Ilcsh:RCoronary StenosisBiology and Life SciencesProteinsmedicine.diseaseTroponinCytoskeletal Proteinsbiology.proteinMyocardial infarction complicationslcsh:QCardiac ElectrophysiologybusinessCoronary AngioplastyElectrocardiographyBiomarkersPLOS ONE
researchProduct

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

2020

Abstract Aims To evaluate the impact of the COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational, nationwide survey to collect data on admissions for acute myocardial infarction (AMI) at Italian CCUs throughout a 1 week period during the COVID-19 outbreak, compared with the equivalent week in 2019. We observed a 48.4% reduction in admissions for AMI compared with the equivalent week in 2019 (P < 0.001). The reduction was significant for both ST-segment elevation myocardial infarction [STEMI; 26.5%, 95% confidence interval (CI) 21.7–32.3; P = 0.009] and non-STEMI (NSTEMI; 65.1%, 95% CI 60.3–70.3; P …

MaleMyocardial Infarction030204 cardiovascular system & hematologySettore MED/110302 clinical medicineAcute myocardial infarction Cardiac care units STEMI Aged Aged 80 and over COVID-19 Female Hospitalization Humans Italy Male Middle Aged SARS-CoV-2 Betacoronavirus Coronavirus Infections Myocardial Infarction Pandemics Pneumonia ViralCase fatality rate80 and overMedicine030212 general & internal medicineMyocardial infarctionViralAged 80 and overAcute myocardial infarction; Cardiac care units; COVID-19; SARS-CoV2; STEMI; Aged; Aged 80 and over; Female; Hospitalization; Humans; Italy; Male; Middle Aged; Betacoronavirus; Coronavirus Infections; Myocardial Infarction; Pandemics; Pneumonia ViralMiddle AgedHospitalizationItalyFemaleCardiology and Cardiovascular MedicineCoronavirus InfectionsHumanmedicine.medical_specialtyPneumonia ViralFast Track Clinical ResearchCardiac care unitsAcute myocardial infarctionSTEMI03 medical and health sciencesBetacoronavirusCardiac care unitHumansAcute myocardial infarction; COVID-19; Cardiac care units; SARS-CoV2; STEMIcardiovascular diseasesPandemicsAgedBetacoronaviruPandemicbusiness.industryCoronavirus InfectionSARS-CoV-2COVID-19Pneumoniamedicine.diseaseacute myocardial infarction; cardiac care units; COVID-19; SARS-CoV2; STEMIConfidence intervalRelative riskEmergency medicineSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARESARS-CoV2Myocardial infarction complicationsObservational studyMyocardial infarction diagnosisbusinessComplication
researchProduct

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

2015

BACKGROUND: Cardiovascular morbidity and mortality are higher among patients with type 2 diabetes, particularly those with concomitant cardiovascular diseases, than in most other populations. We assessed the effects of lixisenatide, a glucagon-like peptide 1-receptor agonist, on cardiovascular outcomes in patients with type 2 diabetes who had had a recent acute coronary event.METHODS: We randomly assigned patients with type 2 diabetes who had had a myocardial infarction or who had been hospitalized for unstable angina within the previous 180 days to receive lixisenatide or placebo in addition to locally determined standards of care. The trial was designed with adequate statistical power to …

MaleMyocardial InfarctionKaplan-Meier Estimate2700 General MedicineType 2 diabetesAnginachemistry.chemical_compoundTreatment FailureMyocardial infarctionResearch Support Non-U.S. Gov'tHemoglobin AGeneral MedicineAnginaMiddle AgedMulticenter StudyCardiovascular DiseasesRandomized Controlled TrialCardiologyFemalelixisenatideType 2medicine.medical_specialtyAcute coronary syndromeGlycosylated610 Medicine & healthUnstableGlucagon-Like Peptide-1 Receptor11171 Cardiocentro TicinoLixisenatideAcute Coronary Syndrome; Aged; Angina Unstable; Cardiovascular Diseases; Diabetes Mellitus Type 2; Female; Glucagon-Like Peptide-1 Receptor; Hemoglobin A Glycosylated; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peptides; Proportional Hazards Models; Treatment FailureInternal medicineJournal ArticleDiabetes MellitusmedicineHumansHypoglycemic AgentsAngina UnstableAcute Coronary SyndromeAgedProportional Hazards ModelsHemoglobin A GlycosylatedUnstable anginabusiness.industrySemaglutideta3121medicine.diseaseDiabetes Mellitus Type 2chemistryMyocardial infarction complicationsPeptidesbusinessNew England Journal of Medicine
researchProduct

Pre-Infarction Angina and Outcomes in Non-ST-Segment Elevation Myocardial Infarction: Data from the RICO Survey

2012

BACKGROUND: The presence of pre-infarction angina (PIA) has been shown to confer cardioprotection after ST-segment elevation myocardial infarction (STEMI). However, the clinical impact of PIA in non-ST-segment elevation myocardial infarction (NSTEMI) remains to be determined. METHODS AND RESULTS: From the obseRvatoire des Infarctus de Côte d'Or (RICO) survey, 1541 consecutive patients admitted in intensive care unit with a first NSTEMI were included. Patients who experienced chest pain <7 days before the episode leading to admission were defined as having PIA and were compared with patients without PIA. Incidence of in-hospital ventricular arrhythmias (VAs), heart failure and 30-day mortali…

MaleNon-Clinical MedicineMyocardial Infarctionlcsh:MedicineInfarctionCoronary AngiographyCardiovascularChest painAnginaIschemiaST segmentProspective StudiesMyocardial infarctionlcsh:ScienceMultidisciplinaryData CollectionClinical PharmacologyMiddle AgedAnginaPrognosisTreatment OutcomeCardiologyMedicineFemaleFrancemedicine.symptomResearch ArticleDrugs and Devicesmedicine.medical_specialtyCritical CareCardiologyHealth InformaticsCardiovascular PharmacologyAngina PectorisIntensive careInternal medicinemedicineHumansAgedHealth Care Policybusiness.industrylcsh:RArrhythmias Cardiacmedicine.diseaseHealth SurveysHeart failureMultivariate AnalysisMyocardial infarction complicationslcsh:QHealth StatisticsbusinessPLoS ONE
researchProduct